Researchers at Rush Seek to Block Progression of Alzheimer's Disease with Novel Medication that Targets the Source
October 06, 2008
October 06, 2008
CHICAGO, Oct. 6 -- Rush University issued the following news release:
Researchers are conducting studies on an experimental medication to block nerve damage and inflammation in the brain that can lead to progressive memory loss and behavioral changes in people with Alzheimer's disease. Current Alzheimer's disease therapies focus on improving symptoms versus attacking the root of the disease progression; 400 volunteers with mild to moderate Alzheimer's disease are needed to further . . .
Researchers are conducting studies on an experimental medication to block nerve damage and inflammation in the brain that can lead to progressive memory loss and behavioral changes in people with Alzheimer's disease. Current Alzheimer's disease therapies focus on improving symptoms versus attacking the root of the disease progression; 400 volunteers with mild to moderate Alzheimer's disease are needed to further . . .